› Forums › General Melanoma Community › Pregnancy and Zelboraf
- This topic has 6 replies, 2 voices, and was last updated 14 years, 1 month ago by
Richard_K.
- Post
- Replies
-
-
- December 5, 2011 at 11:15 pm
-
- December 5, 2011 at 11:15 pm
-
- December 5, 2011 at 11:15 pm
-
- December 6, 2011 at 12:19 am
I am still part of the Zelboraf phase II study and earlier today I reviewed the "Consent" document I signed as a condition of participation in the study. It read in part under a section titled MEN ONLY, "You must agree to use a method of birth control judged to be effective by the study doctor and which will not interfere with the proposed study. You must continue to use birth control during the study and for at least 6 months after your last dose of the study drug." There is more, but this is the main point of this section. Hope this helps.
Dick
-
- December 6, 2011 at 12:19 am
I am still part of the Zelboraf phase II study and earlier today I reviewed the "Consent" document I signed as a condition of participation in the study. It read in part under a section titled MEN ONLY, "You must agree to use a method of birth control judged to be effective by the study doctor and which will not interfere with the proposed study. You must continue to use birth control during the study and for at least 6 months after your last dose of the study drug." There is more, but this is the main point of this section. Hope this helps.
Dick
-
- December 6, 2011 at 12:19 am
I am still part of the Zelboraf phase II study and earlier today I reviewed the "Consent" document I signed as a condition of participation in the study. It read in part under a section titled MEN ONLY, "You must agree to use a method of birth control judged to be effective by the study doctor and which will not interfere with the proposed study. You must continue to use birth control during the study and for at least 6 months after your last dose of the study drug." There is more, but this is the main point of this section. Hope this helps.
Dick
-
- You must be logged in to reply to this topic.